Pages that link to "Q91586265"
Jump to navigation
Jump to search
The following pages link to Marc De Hert (Q91586265):
Displaying 24 items.
- Effects of cannabis use on age at onset in schizophrenia and bipolar disorder (Q34128935) (← links)
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (Q34623350) (← links)
- Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study (Q34708413) (← links)
- Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice (Q37835961) (← links)
- Prevalence and correlates of seclusion and restraint use in children and adolescents: a systematic review (Q37836480) (← links)
- Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation (Q37908905) (← links)
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs (Q37947095) (← links)
- Review: people with schizophrenia or other mental illnesses have a lower rate of invasive coronary interventions after acute coronary syndrome (Q37947104) (← links)
- Metaphor interpretation and use: A window into semantics in schizophrenia (Q38486776) (← links)
- Endogenic and Iatrogenic Diabetes Mellitus in Drug-naïve Schizophrenia: The Role of Olanzapine and its Place in the Psychopharmacological Treatment Algorithm (Q42917751) (← links)
- A head-to-head comparison of sertindole and risperidone on metabolic parameters (Q42928643) (← links)
- Lack of physical activity during leisure time contributes to an impaired health related quality of life in patients with schizophrenia (Q48691297) (← links)
- Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: Results from a 3-month prospective open-label study (Q51374707) (← links)
- Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone (Q51391762) (← links)
- Reliability, minimal detectable changes, practice effects and correlates of the 6-min walk test in patients with schizophrenia (Q51621122) (← links)
- Eurofit test battery in patients with schizophrenia or schizoaffective disorder: Reliability and clinical correlates (Q51809750) (← links)
- Body-directed techniques on psychomotor therapy for people with schizophrenia: a review of the literature (Q54702061) (← links)
- High prevalence of Helicobacter pylori in institutionalized schizophrenic patients (Q73763783) (← links)
- Relationships between obesity, functional exercise capacity, physical activity participation and physical self-perception in people with schizophrenia (Q83158623) (← links)
- Association of the metabolic syndrome with physical activity performance in patients with schizophrenia (Q83583361) (← links)
- Clinical assessment of the ultra high risk of developing a a psychotic disorder; review and critical reflection (Q83612286) (← links)
- Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study (Q90348380) (← links)
- The sublingual use of atropine in the treatment of clozapine-induced sialorrhea: A systematic review (Q91586269) (← links)
- Lower emotional complexity as a prospective predictor of psychopathology in adolescents from the general population (Q97553428) (← links)